Business description: Abcam Plc

Sales by Activity: Abcam Plc
| Fiscal Period: December | 2019 (GBP) | 2020 (GBP) | 2021 (GBP) | 2022 (GBP) |
|---|---|---|---|---|
Sales of Antibodies and Related Products | 260M | 260M | 315M | 362M |
Geographical breakdown of sales: Abcam Plc
| Fiscal Period: December | 2019 (GBP) | 2020 (GBP) | 2021 (GBP) | 2022 (GBP) |
|---|---|---|---|---|
The Americas | - | 112M | 130M | 162M |
EMEA | - | 69.3M | 84.3M | 90.1M |
China | 39.9M | 39.5M | 58.2M | 62.9M |
Rest of Asia | - | 20M | 23.8M | 28.3M |
Japan | 16.9M | 18.8M | 18.7M | 17.9M |
United Kingdom (UK) | 13.6M | - | - | - |
Other Countries | 58.7M | - | - | - |
Germany | 15.2M | - | - | - |
United States (US) | 116M | - | - | - |
Executive Committee: Abcam Plc
| Manager | Title | Age | Since |
|---|---|---|---|
Alan Hirzel
CEO | Chief Executive Officer | 58 | 2014-09-08 |
Markus Lusser
PSD | President | 58 | 2024-03-17 |
Michael Baldock
DFI | Director of Finance/CFO | 62 | 2020-02-02 |
Tommy J. Thomas
IRC | Investor Relations Contact | - | 2022-06-26 |
Sun Yi
SAM | Sales & Marketing | - | 2018-09-30 |
Composition of the Board of Directors: Abcam Plc
| Director | Title | Age | Since |
|---|---|---|---|
Alan Hirzel
BRD | Director/Board Member | 58 | 2013-12-31 |
Mara Aspinall
BRD | Director/Board Member | 63 | 2015-09-13 |
Giles Kerr
BRD | Director/Board Member | 67 | 2018-12-11 |
Michael Baldock
BRD | Director/Board Member | 62 | 2020-02-02 |
Luba Greenwood
BRD | Director/Board Member | 47 | 2022-09-11 |
Markus Lusser
BRD | Director/Board Member | 58 | 2025-07-28 |
Company details: Abcam Plc

Biopharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.25% | +15.18% | +686.42% | +98.66% | 79.4B | ||
| -3.60% | -4.99% | +35.24% | -9.13% | 78.69B | ||
| +2.80% | +3.60% | -6.34% | -27.82% | 59.52B | ||
| -0.89% | +0.19% | -6.63% | +172.79% | 46.58B | ||
| +2.49% | +0.14% | -8.95% | +33.71% | 46.53B | ||
| +0.64% | +4.45% | +65.19% | -11.25% | 33.63B | ||
| +1.34% | +0.03% | +48.64% | +112.75% | 25.11B | ||
| -3.56% | -0.47% | +3.11% | +135.37% | 22.13B | ||
| +0.73% | -0.95% | +57.27% | +97.04% | 15.31B | ||
| Average | -0.01% | +4.30% | +97.10% | +66.90% | 45.21B | |
| Weighted average by Cap. | -0.14% | +6.71% | +148.76% | +54.09% |

















